Revenue Compliance

Continual Improvement Webinar

Expires: May 9, 2024

Video length: 58:00


This “Continual Improvement Webinar” will provide an overview of the latest hot topics regarding laboratory compliance billing, such as PAMA and COVID. The speaker also will review the seven fundamental elements of a laboratory compliance program, ordering documentation requirements, OIG and CMS reviews, national and local coverage determination, PLA codes, and the gap-filled fee process. 


Teresa Beard, MBA 

Regulatory Process Manager 
Revenue Cycle 
Mayo Clinic, Jacksonville, Florida

Learning objectives

Upon completion of this activity, participants should be able to:

  • Develop a compliance policy.
  • Describe OIG and CMS probe reviews.
  • Gain knowledge of CMS billing guidelines for current hot topics.
  • Submit national and local coverage determinations for laboratory tests.
  • Demonstrate the process for PLA codes and the gap-filled fee process.

Intended audience

This webinar is appropriate for laboratory administrators and managers, quality assurance and control staff, supervisors, and other laboratory personnel who are dedicated to continuous quality and process improvement.


The following types of credit are offered for this event:


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1.0 contact hour.

To obtain credit

1. Watch the video.

2. Complete the posttest and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Level of instruction for this program is intermediate.

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

MCL Education

This post was developed by our Education and Technical Publications Team.